Seeing Is Believing
IMVT is currently covered by 12 analysts with an average price target of $40.2. This is a potential upside of $10.78 (36.64%) from yesterday's end of day stock price of $29.42.
Immunovant 's activity chart (see below) currently has 55 price targets and 83 ratings on display. The stock rating distribution of IMVT is 95.92% BUY and 4.08% HOLD.
Analysts average stock forecasts to be materialized ratio is 71.84% with an average time for these price targets to be met of 197.43 days.
Highest price target for IMVT is $52, Lowest price target is $36, average price target is $40.2.
Most recent stock forecast was given by DANIELLE BRILL from RAYMOND JAMES on 10-Oct-2024. First documented stock forecast 07-Jan-2020.
Currently out of the existing stock ratings of IMVT, 47 are a BUY (95.92%), 2 are a HOLD (4.08%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$36
$6.61 (22.49%)
$40
26 days ago
(10-Oct-2024)
2/3 (66.67%)
$6.07 (20.28%)
35
Buy
$51
$21.61 (73.53%)
$51
1 months 6 days ago
(30-Sep-2024)
12/18 (66.67%)
$22.49 (78.88%)
279
Buy
1 months 27 days ago
(09-Sep-2024)
4/5 (80%)
$7.25 (19.21%)
113
Buy
$41
$11.61 (39.50%)
$56
2 months 23 days ago
(13-Aug-2024)
1/5 (20%)
$11.21 (37.63%)
3
Buy
$48
$18.61 (63.32%)
$48
7 months 11 days ago
(25-Mar-2024)
7/11 (63.64%)
$16.78 (53.75%)
275
What is IMVT (Immunovant ) average time for price targets to be met?
Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?
Which analyst has the most public recommendations on IMVT (Immunovant )?
Which analyst is the currently most bullish on IMVT (Immunovant )?
Which analyst is the currently most reserved on IMVT (Immunovant )?